Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Its prevalence ranges between 5 and 21% 1 , depending on the diagnostic criteria, with higher frequency in women with obesity and specific ethnic groups 2,3
Tirzepatide medications include: , which is approved for weight loss and obstructive sleep apnea as a once-weekly injection
To schedule an appointment please call: 703-532-4892 x2 References: Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL
Week-by-week dosage comparison Weight loss comparison at matched timepoints *Tirzepatide 24 and 48-week figures estimated from SURMOUNT-1 trajectory data, as primary endpoint was 72 weeks
US$ 28.25
US$ 25.10
US$ 24.71
US$ 25.01
US$ 20.84
US$ 23.78
